Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Rockwell Medical's Enterprise Value is €16.79 Mil.
Rockwell Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €2.50 Mil. Therefore, Rockwell Medical's EV-to-OCF for today is 6.70.
The historical rank and industry rank for Rockwell Medical's EV-to-OCF or its related term are showing as below:
STU:RWM'
s EV-to-OCF Range Over the Past 10 Years
Min: -49.82 Med: -4.65 Max: 42.36
Current: 6.85
During the past 13 years, the highest EV-to-OCF of Rockwell Medical was 42.36. The lowest was -49.82. And the median was -4.65.
STU:RWM's EV-to-OCF is ranked better than 60% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 10.88
vs STU:RWM: 6.85
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Rockwell Medical's PE Ratio (TTM) for today is calculated as:
Rockwell Medical's share price for today is €4.80.
Rockwell Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.152.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Rockwell Medical EV-to-OCF Related Terms
Rockwell Medical EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Rockwell Medical's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rockwell Medical EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Rockwell Medical's EV-to-OCF falls into.
Rockwell Medical's current Enterprise Value is €16.79 Mil.
Rockwell Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.50 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rockwell Medical (STU:RWM) has a EV-to-OCF of 6.70 as of Aug. 19, 2026. According to the industry distribution chart, Rockwell Medical ranks #402 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 40%.
Is Rockwell Medical's EV-to-OCF too high?
Rockwell Medical's current EV-to-OCF is 6.70. The Drug Manufacturers industry median EV-to-OCF is 10.88. Rockwell Medical's value of 6.70 is 38.4% below this industry median. Based on the distribution chart, Rockwell Medical ranks #402 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Rockwell Medical has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's EV-to-OCF compare to BTAI and MRMD?
According to the Drug Manufacturers industry distribution chart, Rockwell Medical ranks #402 out of 1005 companies for EV-to-OCF. This puts Rockwell Medical in the upper half of its industry. The industry median EV-to-OCF is 10.88. Rockwell Medical's value of 6.70 is 38.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.88, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rockwell Medical's current EV-to-OCF of 6.70 is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rockwell Medical's current EV-to-OCF is 6.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (STU:RWM) is currently considered Fairly Valued. The stock's GF Value™ is €5.23, compared to a current price of €4.80 — trading 8.2% below its estimated fair value. The current EV-to-OCF is 6.70 and 38.4% below the Drug Manufacturers industry median of 10.88. Rockwell Medical's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Rockwell Medical (STU:RWM), the current EV-to-OCF is 6.70 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rockwell Medical (STU:RWM) Overvalued in 2026?
Based on GuruFocus' analysis, Rockwell Medical stock appears to be undervalued.
The current stock price of €4.80 is trading 8.2% below its estimated GF Value™ of €5.23.
GuruFocus considers Rockwell Medical to be Fairly Valued.
Key valuation signals for STU:RWM:
EV-to-OCF: 6.70
GF Value™: €5.23 vs. price of €4.80 (8.2% below fair value)
Industry Position: 38.4% below the Drug Manufacturers median (#402 of 1005)
No single metric tells the full story. See the STU:RWM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
48GF Score
Get the complete analysis for STU:RWM
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:RWM has been successfully added to your 
